Bortezomib will increase the degree or influence of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Elevated flibanserin adverse outcomes might come about if coadministered with numerous weak CYP3A4 inhibitors. To lower the risk of dizziness and lightheadedness, rise up slowly and gradually when increasing from a sitting or https://jessicay110kvg3.spintheblog.com/profile